etodolac has been researched along with Skin Neoplasms in 2 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
Skin Neoplasms: Tumors or cancer of the SKIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapadia, GJ | 1 |
| Azuine, MA | 1 |
| Shigeta, Y | 1 |
| Suzuki, N | 1 |
| Tokuda, H | 1 |
| Abo Aasy, NK | 1 |
| Ragab, D | 1 |
| Sallam, MA | 1 |
| Abdelmonsif, DA | 1 |
| Aly, RG | 1 |
| Elkhodairy, KA | 1 |
2 other studies available for etodolac and Skin Neoplasms
| Article | Year |
|---|---|
Chemopreventive activities of etodolac and oxyphenbutazone against mouse skin carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation | 2010 |
A comparative study: the prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemoprevention; Cyclooxygenase 2; | 2019 |